BIIB vs IBEX · P/E 21, rev $9.89B vs P/E 13, rev $558.3M
Biogen Inc (BIIB) versus IBEX Ltd (IBEX) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
IBEX Ltd (IBEX) is a information technology services company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported IBEX revenue for 2025-06-30 was $558.3M. Net income was $36.9M. IBEX currently screens at market cap $388.5M and trailing P/E 12.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. IBEX currently screens at market cap $388.5M and trailing P/E 12.9.
Not investment advice. Open the BIIB and IBEX stock pages for the full models.
Not investment advice.